Epidarex Capital leads Series A round for Clyde Biosciences
UK-based drug toxicity testing company Clyde Biosciences has secured 2 million pounds in Series A funding. Epidarex Capital led the round with participation from the Scottish Investment Bank and Glasgow University Holdings Ltd.
13 April 2015•5 mins read
